Bencyclane

DB13488ExperimentalSmall molecule

A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Mechanism: Pharmacologically active on Voltage-dependent L-type calcium channel
Curator reviewed
Formula / weight: C₁₉H₃₁NO · 289.463 g/mol (avg)

Resolves to

Compound

UNII6I97Z6S135CAS2179-37-5ChEMBLCHEMBL2110767ChEBI135205

Clinical / RWD

RxNorm1367ATCC04AX11

Structure

InChIKeyFYJJXENSONZJRG-UHFFFAOYSA-NSMILESCN(C)CCCOC1(CC2=CC=CC=C2)CCCCCC1

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,003Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 16 drug categories

5+ReferencesStructured and connected to the statements they support

Which companies are running trials of Bencyclane, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account